Microphthalmia, Anophthalmia, and Coloboma Genetic Epidemiology in Children
Launched by BAYLOR COLLEGE OF MEDICINE · Feb 27, 2024
Trial Information
Current as of July 09, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking to learn more about certain eye conditions in children, specifically Microphthalmia, Anophthalmia, and Coloboma (also known as MAC). The researchers want to understand how these conditions affect children's appearance and how changes in their DNA might influence the chances of developing MAC. By studying families with these conditions, they hope to gather important information that could help improve care and support for affected children.
Families with children diagnosed with MAC are invited to participate in this study. Eligible participants include the children themselves, their parents, and their siblings, and they should be able to speak either English or Spanish. During the study, participants may be asked to provide information about their family's health and may undergo some genetic testing. This research is a valuable opportunity to contribute to a better understanding of these eye conditions, which could lead to improved outcomes for children in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. All MAC cases
- • 2. Parents of the above children.
- • 3. Siblings of the above children.
- • 4. English or Spanish speaking.
- Exclusion Criteria:
- • All subjects who do not meet the inclusion criteria listed above.
About Baylor College Of Medicine
Baylor College of Medicine is a leading academic institution dedicated to advancing health through innovative research, education, and clinical care. Located in Houston, Texas, it is renowned for its commitment to excellence in medical education and translational research, fostering collaborations that bridge laboratory discoveries with clinical application. As a clinical trial sponsor, Baylor College of Medicine leverages its robust infrastructure, interdisciplinary expertise, and access to diverse patient populations to conduct cutting-edge clinical studies aimed at improving patient outcomes and enhancing therapeutic approaches across a wide range of medical conditions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Houston, Texas, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported